In this issue:
Sacituzumab govitecan-hziy in pretreated metastatic TNBC
Support for dose-dense chemotherapy in early disease
Adjuvant denosumab in postmenopausal hormone receptor+ disease
18F-FES PET-CT for assessing ER status
Atezolizumab shows clinical benefit in metastatic TNBC
Normal BMI and postmenopausal breast cancer risk
iCBT lowers menopausal symptoms after breast cancer
6 cycles of TC when anthracycline is contraindicated?
Celecoxib, COX-2 expression & survival in breast cancer
Preoperative breast MRI for DCIS staging
Please login below to download this issue (PDF)